Marvell Technology, Inc. (MRVL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 272.05 |
| Open | 269.68 |
| Day High | 274.95 |
| Day Low | 237.2 |
| 52-Week High | 329.88 |
| 52-Week Low | 61.44 |
| Volume | 38.58M |
| Average Volume | 42.83M |
| Market Cap | 214.58B |
| PE | 80.95 |
| EPS | 3.03 |
| Moving Average 50 Days | 223.63 |
| Moving Average 200 Days | 122.63 |
| Change | -26.76 |
Toronto Stock Exchange, Marvel Biosciences Corp., The View from the C-Suite
Newsfile
Dec 22, 2025 7:07 PM GMT
Toronto, Ontario--(Newsfile Corp. - December 22, 2025) - Rod Matheson, Chief Executive Officer, and Mark Williams, Chief Strategy Officer, from Marvel Biosciences Corp. (the "Company") (TSXV: MRVL), shares the Company's story in an interview with TMX